May 7, 2025 04:33PM Genelux Corporation (GNLX) Tops Q1 EPS by 1c

May 7, 2025 07:17AM Genelux Corp. (GNLX) PT Raised to $31 at H.C. Wainwright

Apr 8, 2025 09:35AM Benchmark Reiterates Speculative Buy Rating on Genelux Corp. (GNLX)

Mar 31, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Genelux Corp. (GNLX)

Mar 26, 2025 08:41AM Benchmark Reiterates Speculative Buy Rating on Genelux Corp. (GNLX)

Mar 26, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Genelux Corp. (GNLX)

Mar 25, 2025 08:33AM Genelux (GNLX) and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer

Mar 25, 2025 08:33AM Genelux (GNLX) Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec

Mar 25, 2025 08:31AM Genelux (GNLX) Prices 3M Share Offering at $3.50/sh

Feb 3, 2025 06:46AM Genelux (GNLX) Appoints Matthew Pulisic as CFO

Nov 15, 2024 06:52AM Genelux Corp. (GNLX) PT Lowered to $30 at H.C. Wainwright

Oct 29, 2024 05:32AM Guggenheim Starts Genelux Corp. (GNLX) at Buy

Oct 22, 2024 04:04PM Genelux (GNLX) Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer

Aug 27, 2024 04:07PM Roth/MKM Starts Genelux Corp. (GNLX) at Buy

Aug 15, 2024 04:13PM Genelux Corporation (GNLX) Tops Q2 EPS by 2c